Diabetes Mellitus, Type 2
"Diabetes Mellitus, Type 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Descriptor ID |
D003924
|
| MeSH Number(s) |
C18.452.394.750.149 C19.246.300
|
| Concept/Terms |
Diabetes Mellitus, Type 2- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Noninsulin-Dependent
- Diabetes Mellitus, Ketosis-Resistant
- Diabetes Mellitus, Ketosis Resistant
- Ketosis-Resistant Diabetes Mellitus
- Diabetes Mellitus, Non Insulin Dependent
- Diabetes Mellitus, Non-Insulin-Dependent
- Non-Insulin-Dependent Diabetes Mellitus
- Diabetes Mellitus, Stable
- Stable Diabetes Mellitus
- Diabetes Mellitus, Type II
- NIDDM
- Diabetes Mellitus, Noninsulin Dependent
- Diabetes Mellitus, Maturity-Onset
- Diabetes Mellitus, Maturity Onset
- Maturity-Onset Diabetes Mellitus
- Maturity Onset Diabetes Mellitus
- MODY
- Diabetes Mellitus, Slow-Onset
- Diabetes Mellitus, Slow Onset
- Slow-Onset Diabetes Mellitus
- Type 2 Diabetes Mellitus
- Noninsulin-Dependent Diabetes Mellitus
- Noninsulin Dependent Diabetes Mellitus
- Maturity-Onset Diabetes
- Diabetes, Maturity-Onset
- Maturity Onset Diabetes
- Type 2 Diabetes
- Diabetes, Type 2
- Diabetes Mellitus, Adult-Onset
- Adult-Onset Diabetes Mellitus
- Diabetes Mellitus, Adult Onset
|
Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus, Type 2".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus, Type 2".
This graph shows the total number of publications written about "Diabetes Mellitus, Type 2" by people in this website by year, and whether "Diabetes Mellitus, Type 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 9 | 2 | 11 |
| 1995 | 18 | 3 | 21 |
| 1996 | 20 | 0 | 20 |
| 1997 | 15 | 3 | 18 |
| 1998 | 5 | 3 | 8 |
| 1999 | 5 | 0 | 5 |
| 2000 | 23 | 6 | 29 |
| 2001 | 11 | 4 | 15 |
| 2002 | 13 | 5 | 18 |
| 2003 | 4 | 2 | 6 |
| 2004 | 16 | 4 | 20 |
| 2005 | 21 | 2 | 23 |
| 2006 | 22 | 3 | 25 |
| 2007 | 9 | 5 | 14 |
| 2008 | 19 | 8 | 27 |
| 2009 | 15 | 7 | 22 |
| 2010 | 19 | 4 | 23 |
| 2011 | 29 | 7 | 36 |
| 2012 | 23 | 6 | 29 |
| 2013 | 23 | 4 | 27 |
| 2014 | 37 | 5 | 42 |
| 2015 | 23 | 3 | 26 |
| 2016 | 31 | 3 | 34 |
| 2017 | 21 | 5 | 26 |
| 2018 | 22 | 6 | 28 |
| 2019 | 32 | 3 | 35 |
| 2020 | 16 | 8 | 24 |
| 2021 | 27 | 4 | 31 |
| 2022 | 35 | 0 | 35 |
| 2023 | 33 | 0 | 33 |
| 2024 | 12 | 3 | 15 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diabetes Mellitus, Type 2" by people in Profiles.
-
Meat consumption and incident type 2 diabetes: an individual-participant federated meta-analysis of 1ยท97 million adults with 100?000 incident cases from 31 cohorts in 20 countries. Lancet Diabetes Endocrinol. 2024 Sep; 12(9):619-630.
-
Effectiveness of Multilevel and Multidomain Interventions to Improve Glycemic Control in U.S. Racial and Ethnic Minority Populations: A Systematic Review and Meta-analysis. Diabetes Care. 2024 Sep 01; 47(9):1704-1712.
-
As Good as it Gets: SGLT2 Inhibitors in Cardiac Amyloidosis. J Am Coll Cardiol. 2024 Jun 18; 83(24):2423-2425.
-
Type 2 Diabetes. Ann Intern Med. 2024 Jun; 177(6):ITC81-ITC96.
-
Epidemiology of Heart Failure and the Discovery of the Cardioprotective Effects of SGLT2 Inhibitors. JACC Heart Fail. 2024 Jun; 12(6S):S1-S3.
-
Summary and Panel Discussion. JACC Heart Fail. 2024 Jun; 12(6S):S10-S11.
-
Individualizing Care for Older Adults With Diabetes Amid the Revolution in Pharmacotherapy. JAMA Intern Med. 2024 Apr 01; 184(4):435-436.
-
Glucagon-like peptide-1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta-analysis and meta-regression. Diabetes Obes Metab. 2024 Jun; 26(6):2209-2228.
-
Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials. BMJ Open. 2024 Mar 19; 14(3):e076444.
-
Willingness to take less medication for type 2 diabetes among older patients: The Diabetes & Aging Study. J Am Geriatr Soc. 2024 Jul; 72(7):1985-1994.